Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy
Abstract We report the identification of a de novo GABRA1 (R214C) variant in a child with epileptic encephalopathy (EE), describe its functional characterization and pathophysiology, and evaluate its potential therapeutic options. The GABRA1 (R214C) variant was identified using whole exome sequencin...
Main Authors: | Yun-Fei Bai, Michelle Chiu, Elizabeth S. Chan, Peter Axerio-Cilies, Jie Lu, Linda Huh, Mary B. Connolly, Ilaria Guella, Matthew J. Farrer, Zhi-Qing David Xu, Lidong Liu, Michelle Demos, Yu Tian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13041-019-0513-9 |
Similar Items
-
Correction to: Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy
by: Yun-Fei Bai, et al.
Published: (2020-03-01) -
Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders
by: Wenlin Chen, et al.
Published: (2022-03-01) -
Neuropathology of epileptic encephalopathies and non-paroxysmal epileptic disorders and principles of their treatment
by: L. R. Zenkov
Published: (2010-06-01) -
Ohtahara II sydrome as a rare epileptic encephalopathy
by: Akhmadeeva L.R., et al.
Published: (2018-03-01) -
Current understanding and neurobiology of epileptic encephalopathies
by: Stéphane Auvin, et al.
Published: (2016-08-01)